Molecular targets for cancer chemoprevention

William N William1, John V Heymach, Edward S Kim

  • 1Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

Insights

Cancer chemoprevention successes include vaccines against hepatitis B virus and human papillomavirus. Further research into molecular targets aims to expand and personalize cancer prevention strategies for broader clinical application.

Area of Science:

  • Oncology
  • Preventive Medicine
  • Molecular Biology

Background:

  • Hepatitis B virus (HBV) and human papillomavirus (HPV) infections are risk factors for hepatocellular and cervical cancers, respectively.
  • Vaccines targeting HBV and HPV represent significant achievements in clinical cancer chemoprevention.
  • Molecularly targeted agents have demonstrated potential in preventing specific cancers like breast, colorectal, and prostate cancer.

Purpose of the Study:

  • To review the current state of clinical cancer chemoprevention.
  • To highlight successes and limitations in translating chemoprevention strategies to clinical practice.
  • To emphasize the future potential of molecular targets in expanding and personalizing cancer prevention.

Main Methods:

  • Literature review of established cancer chemoprevention strategies.
  • Analysis of molecularly targeted agents used in cancer prevention.
  • Discussion of the challenges and future directions in clinical chemoprevention research.

Main Results:

  • Vaccines for HBV and HPV are recognized as major clinical cancer chemoprevention successes.
  • Specific molecularly targeted agents (raloxifene, tamoxifen, celecoxib, finasteride) show efficacy in preventing certain cancers or pre-cancerous conditions.
  • Broad clinical translation of chemoprevention remains a challenge, despite demonstrated successes.

Conclusions:

  • Cancer chemoprevention has achieved notable successes, particularly with vaccines against viral oncogenesis.
  • Molecularly targeted agents offer promising avenues for preventing various cancers.
  • Continued research into molecular targets is crucial for expanding the scope and personalizing cancer chemoprevention for wider clinical adoption.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...